4956 — Epileds Technologies Income Statement
0.000.00%
Last trade - 00:00
- TWD1.97bn
- TWD2.43bn
- TWD1.13bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,191 | 1,303 | 1,763 | 1,195 | 1,132 |
Cost of Revenue | |||||
Gross Profit | 119 | 193 | 389 | 108 | 18.7 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,318 | 1,289 | 1,607 | 1,298 | 1,304 |
Operating Profit | -126 | 14.3 | 155 | -104 | -172 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -131 | 18.3 | 161 | -90.7 | -168 |
Provision for Income Taxes | |||||
Net Income After Taxes | -127 | 16.2 | 144 | -72.3 | -139 |
Net Income Before Extraordinary Items | |||||
Net Income | -127 | 16.2 | 144 | -72.3 | -139 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -127 | 16.2 | 144 | -72.3 | -139 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.25 | 0.161 | 1.43 | -0.72 | -1.38 |
Dividends per Share |